Cargando…
下调βⅢ-tubulin逆转肺腺癌A549/Taxol细胞株紫杉醇耐药
BACKGROUND AND OBJECTIVE: Chemotherapy drug resistance is the primary causes of death in patients with pulmonary carcinoma which make tumor recurrence or metastasis.β-tubulin is the main cell targets of anti-microtubule drug.Increased expression of βⅢ-tubulin has been implicated in non-small cell lu...
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
中国肺癌杂志编辑部
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6000364/ https://www.ncbi.nlm.nih.gov/pubmed/25130963 http://dx.doi.org/10.3779/j.issn.1009-3419.2014.08.01 |
Ejemplares similares
-
紫杉醇通过上调TAP-1, TAP-2以及消除调节性T细胞逆转肺癌免疫逃逸
Publicado: (2010) -
STE029逆转肺腺癌EGFR-TKI耐药及其机制研究
Publicado: (2022) -
下调HOTAIR通过提高PTEN表达逆转HCC827细胞吉非替尼耐药
Publicado: (2020) -
MiR-503逆转肺癌耐药细胞株A549/DDP的耐药性及其机制研究
Publicado: (2014) -
IKBKB在人肺腺癌细胞株A549及其耐药细胞株A549/DDP中的表达和意义
Publicado: (2014)